Newton BioCapital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
31
- Portfolio
-
12
- Exits
-
10
Newton BioCapital General Information
Company Description
Founded in 2017, Newton BioCapital is a venture capital firm based in Brussels, Belgium. The firm focuses on investing in biotech and life science sectors in Europe and Japan.
Business Details
Website
www.newtonbiocapital.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- Avenue de Tervueren 273
- 1150 Brussels
- Belgium
Newton BioCapital Investments (31)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Bioxodes | 10-Dec-2025 | Later Stage VC | Biotechnology | Clinical Trials - Phase 2 | ||
| Augustine Therapeutics | 24-Mar-2025 | Drug Discovery | Generating Revenue | |||
| Santero Therapeutics | 11-Mar-2025 | Drug Discovery | Generating Revenue | |||
| Tensegrity Pharma | 31-Jan-2025 | Drug Discovery | Pre-Clinical Trials | |||
| AdipoPharma | 18-Nov-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| AbolerIS Pharma | 01-Aug-2023 | Drug Discovery | Generating Revenue | |||
| EditForce | 22-May-2023 | Drug Discovery | Pre-Clinical Trials | |||
| DeuterOncology | 19-Jan-2023 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Synergia Medical | 19-Jan-2023 | Later Stage VC | Therapeutic Devices | Generating Revenue | ||
| Cellaion | 15-Feb-2022 | Later Stage VC | Drug Discovery | Bankruptcy: Liquidation |
Newton BioCapital Exits (10)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| DeuterOncology | 06-May-2026 | Merger/Acquisition | |
| J-Pharma | 25-Mar-2026 | ||
| Acticor Biotech | 02-Jan-2025 | ||
| PRISM BioLab | 02-Jul-2024 | ||
| Cellaion | 27-May-2024 | ||
| Metabolys | 01-Jan-2023 | ||
| Chromacure | 28-Nov-2022 | ||
| Acticor Biotech | 01-Nov-2021 | ||
| PPMX (Drug Discovery) | 22-Jun-2021 | IPO | |
| Sequana Medical | 11-Feb-2019 | IPO |
Newton BioCapital Investments by Industry, Year, and Region
Newton BioCapital Co-Investors (41)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Carbon ( Belgium ) | 4 |
|
|
||
| ORSA FUND |
|
|
|||
| Société Fédérale de Participations et d'Investissement |
|
|
|||
| Wallonie Entreprendre |
|
|
|||
| Invest.BW |
|
|
Newton BioCapital FAQs
-
What is Newton BioCapital?
Founded in 2017, Newton BioCapital is a venture capital firm based in Brussels, Belgium.
-
When was Newton BioCapital founded?
Newton BioCapital was founded in 2017.
-
Where is Newton BioCapital headquartered?
Newton BioCapital is headquartered in Brussels, Belgium.
-
What is Newton BioCapital's total asset value?
Newton BioCapital has around in total assets under management.
-
How many investments has Newton BioCapital made?
Newton BioCapital has made 31 investments.
-
What has Newton BioCapital invested in?
Newton BioCapital has made numerous investments in companies like Bioxodes, Augustine Therapeutics, and Santero Therapeutics within the Biotechnology and Drug Discovery industries.
-
What has Newton BioCapital invested in recently?
Newton BioCapital's latest investment was on 10-Dec-2025 in Bioxodes, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process